Working Group Meeting, February 4-5, 2008 Agenda

This meeting will be in CLOSED session on Monday, February 4th.

Please note that the OPEN session for this meeting will be on
Tuesday, February 5th from 10:30am to 2:15pm

**Monday, February 4**
Time	Activity	Speaker
8:30 – 8:45	Welcome – Opening Remarks	Al Berg
8:45 – 9:00	Status Updates	David Dotson
9:00 – 12:00	Presentation and Discussion of The EGAPP Supplementary Evidence Review: DNA testing strategies Aimed at Reducing Morbidity and Morality from Lynch Syndrome Discussion of the Draft Recommendation Statement	Technical Consultants & WG Members
12:00 – 1:00	Lunch Guest Speaker	Cecile Janssens, PhD, Erasmus Medical Center, Rotterdam, NL
1:00 – 2:30	Breakout Sessions Breast Cancer Recommendation UGT1A1 Report and Recommendation Statement	WG Members & Consultants
2:30 – 3:00	Report and Discussion on Breakout Session I	WG Members & Consultants
3:00 – 3:15	Break
3:15 – 3:45	Report and Discussion on Breakout Session II	WG Members & Consultants
3:45 – 4:45	Discussion and Planning for Evidence Review for Genetic Testing for Risk of Cardiovascular Disease	WG Members & Consultants
4:45 – 5:00	Wrap-up and Adjourn Closed Session	Al Berg

**Tuesday, February 5**
Time	Activity	Speaker
7:30 – 9:00	Executive Session – Working Group Members only	Al Berg & Staff
9:00 – 10:00	Subcommittee Meetings Methods Topics Products	Steve Teutsch, chair Joan Scott, chair Celia Kaye, chair
10:00 – 10:30	Break
10:30 – 11:00	Open session called to order Overview of Day 1, brief staff updates and outstanding questions	Al Berg & Staff
11:00 – 11:30	EGAPP Stakeholders Group (ESG) Report	Debra Leonard, chair
11:30 – 12:15	Topics Subcommittee Report	Joan Scott
12:15 – 12:30	Public Comment
12:30 – 1:15	Working Lunch Methods Subcommittee Report	Steve Teutsch
1:15 – 2:00	Products Subcommittee Report	Celia Kaye
2:00 – 2:15	Wrap-up and Action Items	Al Berg & Linda Bradley
2:15	Adjourn